ME00987B - Novi postupak sinteze ivabradina i njegovih soli sa farmaceutski prihvatljivom kiselinom - Google Patents

Novi postupak sinteze ivabradina i njegovih soli sa farmaceutski prihvatljivom kiselinom

Info

Publication number
ME00987B
ME00987B MEP-2010-55A MEP5510A ME00987B ME 00987 B ME00987 B ME 00987B ME P5510 A MEP5510 A ME P5510A ME 00987 B ME00987 B ME 00987B
Authority
ME
Montenegro
Prior art keywords
ivabradine
pharmaceutically acceptable
addition salts
acceptable acid
synthesiis
Prior art date
Application number
MEP-2010-55A
Other languages
English (en)
Inventor
Aimėe Dessinges
Bernard Serkiz
Jean-Louis Peglion
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40984744&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME00987(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of ME00987B publication Critical patent/ME00987B/me

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

Postupak sinteze ivabradina formule (I):       i njegovih adicionih soli sa farmaceutski prihvatljivom kiselinom.  
MEP-2010-55A 2009-03-31 2009-03-31 Novi postupak sinteze ivabradina i njegovih soli sa farmaceutski prihvatljivom kiselinom ME00987B (me)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0901555A FR2943667B1 (fr) 2009-03-31 2009-03-31 Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.

Publications (1)

Publication Number Publication Date
ME00987B true ME00987B (me) 2012-06-20

Family

ID=40984744

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2010-55A ME00987B (me) 2009-03-31 2009-03-31 Novi postupak sinteze ivabradina i njegovih soli sa farmaceutski prihvatljivom kiselinom

Country Status (37)

Country Link
US (1) US8101747B2 (me)
EP (1) EP2241554B1 (me)
JP (1) JP5107382B2 (me)
KR (1) KR101166630B1 (me)
CN (2) CN101851205B (me)
AR (1) AR075977A1 (me)
AT (1) ATE523494T1 (me)
AU (1) AU2010201058B2 (me)
BR (1) BRPI1000735A2 (me)
CA (1) CA2697562C (me)
CL (1) CL2010000254A1 (me)
CY (1) CY1112136T1 (me)
DK (1) DK2241554T3 (me)
EA (1) EA016335B1 (me)
ES (1) ES2373369T3 (me)
FR (1) FR2943667B1 (me)
GE (1) GEP20125460B (me)
HK (2) HK1148748A1 (me)
HR (1) HRP20110915T1 (me)
JO (1) JO2782B1 (me)
MA (1) MA31745B1 (me)
ME (1) ME00987B (me)
MX (1) MX2010003184A (me)
MY (1) MY145611A (me)
NZ (1) NZ584309A (me)
PE (1) PE20100714A1 (me)
PL (1) PL2241554T3 (me)
PT (1) PT2241554E (me)
RS (1) RS51962B (me)
SA (1) SA110310240B1 (me)
SG (1) SG165254A1 (me)
SI (1) SI2241554T1 (me)
TW (1) TWI419879B (me)
UA (1) UA102232C2 (me)
UY (1) UY32500A (me)
WO (1) WO2010112704A1 (me)
ZA (1) ZA201002121B (me)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2471780E (pt) * 2007-05-30 2015-02-24 Ind Swift Lab Ltd Sais oxalato de ivabradina cristalinos e seus polimorfos
CN103848789B (zh) * 2012-11-29 2016-05-18 江苏恒瑞医药股份有限公司 一种伊伐布雷定的制备方法
CN103724266B (zh) * 2014-01-20 2018-12-04 山东诚创医药技术开发有限公司 去甲伊伐布雷定盐及其制备方法和应用
EP3101010A1 (en) 2015-06-03 2016-12-07 Urquima S.A. New method for the preparation of highly pure ivabradine base and salts thereof
CN108530359A (zh) * 2017-03-01 2018-09-14 浙江京新药业股份有限公司 一种伊伐布雷定杂质的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1140049A (en) * 1965-04-02 1969-01-15 Alphachimie S A N-substituted tetrahydrobenzazepines
US3743731A (en) * 1971-03-16 1973-07-03 Schering Corp Substituted benzazepines for producing skeletal muscle relaxation
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2870537A1 (fr) * 2004-05-19 2005-11-25 Servier Lab Nouveau procede de synthese du (1s)-4,5-dimethoxy-1-(methyl aminomethyl-)-benzocyclobutane et de ses sels d'addition, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
EP2097383B1 (en) * 2006-11-30 2012-02-08 Cadila Healthcare Limited Process for preparation of ivabradine hydrochloride
CN101284813B (zh) * 2007-04-12 2012-08-15 上海优拓医药科技有限公司 伊伐布雷定的制备方法
PT2471780E (pt) 2007-05-30 2015-02-24 Ind Swift Lab Ltd Sais oxalato de ivabradina cristalinos e seus polimorfos

Also Published As

Publication number Publication date
CN101851205A (zh) 2010-10-06
CA2697562A1 (fr) 2010-09-30
PL2241554T3 (pl) 2012-01-31
WO2010112704A1 (fr) 2010-10-07
UY32500A (es) 2010-09-30
SG165254A1 (en) 2010-10-28
US20100249397A1 (en) 2010-09-30
HRP20110915T1 (hr) 2011-12-31
CN102603634A (zh) 2012-07-25
UA102232C2 (uk) 2013-06-25
KR20100109526A (ko) 2010-10-08
EP2241554B1 (fr) 2011-09-07
AR075977A1 (es) 2011-05-11
HK1148748A1 (en) 2011-09-16
TWI419879B (zh) 2013-12-21
JP5107382B2 (ja) 2012-12-26
HK1169827A1 (en) 2013-02-08
CA2697562C (fr) 2012-05-15
JO2782B1 (en) 2014-03-15
TW201040144A (en) 2010-11-16
GEP20125460B (en) 2012-03-26
BRPI1000735A2 (pt) 2011-04-19
RS51962B (en) 2012-02-29
DK2241554T3 (da) 2011-12-12
CN102603634B (zh) 2014-04-16
KR101166630B1 (ko) 2012-07-19
AU2010201058B2 (en) 2015-02-05
ATE523494T1 (de) 2011-09-15
PT2241554E (pt) 2011-10-17
CN101851205B (zh) 2013-02-13
CY1112136T1 (el) 2015-11-04
CL2010000254A1 (es) 2011-04-25
MY145611A (en) 2012-03-05
SI2241554T1 (sl) 2012-01-31
NZ584309A (en) 2010-11-26
MX2010003184A (es) 2010-10-05
PE20100714A1 (es) 2010-10-30
EA016335B1 (ru) 2012-04-30
AU2010201058A1 (en) 2010-10-14
ZA201002121B (en) 2010-11-24
MA31745B1 (fr) 2010-10-01
JP2010241809A (ja) 2010-10-28
FR2943667B1 (fr) 2011-05-06
FR2943667A1 (fr) 2010-10-01
ES2373369T3 (es) 2012-02-02
EP2241554A1 (fr) 2010-10-20
US8101747B2 (en) 2012-01-24
SA110310240B1 (ar) 2013-07-28
EA201000397A1 (ru) 2010-12-30

Similar Documents

Publication Publication Date Title
EA200901563A1 (ru) Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
EA201101147A1 (ru) Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
ME00986B (me) Novi postupak sinteze ivabradina i njegovih adicionih soli sa farmaceutski prihvatljivom kiselinom
MY169295A (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
ME00987B (me) Novi postupak sinteze ivabradina i njegovih soli sa farmaceutski prihvatljivom kiselinom
JO2930B1 (en) A new process for the synthesis of ivabradine and salts of addition with a pharmaceutically acceptable acid
JO2854B1 (en) A new method for the synthesis of anfabradine and its added salts with acid is pharmaceutically acceptable.
MY170662A (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
MX349425B (es) Nuevo procedimiento de sintesis del 3-(2-bromo-4,5-dimetoxifenil) propanonitrilo, y aplicacion a la sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
SA113340412B1 (ar) عملية جديدة لتصنيع إيڤابرادين وأملاح إضافة منه مع حمض مقبول صيدلانياً
UA111156C2 (uk) Спосіб синтезу івабрадину і його адитивних солей з фармацевтично прийнятною кислотою
SG165255A1 (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid